2011
DOI: 10.1593/neo.101744
|View full text |Cite
|
Sign up to set email alerts
|

Identification of an Exon 4-Deletion Variant of Epidermal Growth Factor Receptor with Increased Metastasis-Promoting Capacity

Abstract: Several types of epidermal growth factor receptor (EGFR) gene alternations have been observed in human tumors. Here we present a novel EGFR variant with aberrant splicing of exon 4 (named as de4 EGFR). Variant-specific polymerase chain reaction showed that de4 EGFR was expressed in some glioma (4/40), prostate cancer (3/11), and ovarian cancer (3/9) tissues but not in tissues adjacent to tumors or normal tissues. de4 EGFR displayed an enhanced transformation and a higher metastasis-promoting capacity in compar… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
53
0

Year Published

2013
2013
2019
2019

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 62 publications
(53 citation statements)
references
References 31 publications
0
53
0
Order By: Relevance
“…Another example which designates alternative splicing in the formation of EGFR variants is in the case of the EGFR variant de4 EGFR. In this report, de4 EGFR was identified as an EGFR mutant with an aberrant splice joining of exons 3 and 5 and was expressed in 4/40 glioma tissues examined (Wang et al 2011). Similar to other EGFR mutants, de4 EGFR is intrinsically constitutively activated with a low basal tyrosine phosphorylation due to its ability to self-dimerize in the absence of ligand.…”
Section: Alternative Splicing Of Egfrmentioning
confidence: 80%
See 1 more Smart Citation
“…Another example which designates alternative splicing in the formation of EGFR variants is in the case of the EGFR variant de4 EGFR. In this report, de4 EGFR was identified as an EGFR mutant with an aberrant splice joining of exons 3 and 5 and was expressed in 4/40 glioma tissues examined (Wang et al 2011). Similar to other EGFR mutants, de4 EGFR is intrinsically constitutively activated with a low basal tyrosine phosphorylation due to its ability to self-dimerize in the absence of ligand.…”
Section: Alternative Splicing Of Egfrmentioning
confidence: 80%
“…Similar to other EGFR mutants, de4 EGFR is intrinsically constitutively activated with a low basal tyrosine phosphorylation due to its ability to self-dimerize in the absence of ligand. Overexpression of de4 EGFR in U87 glioma cells resulted in increased proliferation, anchorage-independent colony formation, migration, and invasion (Wang et al 2011).…”
Section: Alternative Splicing Of Egfrmentioning
confidence: 95%
“…Moreover, most of them are soluble receptors, lacking an intracellular domain and difficult to mediate ligand-induced signal transductions. Some mutant splicing variants of EGFR have also been reported previously (20,21). A well-recognized one is EGFRvIII.…”
Section: Introductionmentioning
confidence: 82%
“…For example, alternative splicing of epidermal growth factor receptor results in the expression of a constitutively active isoform that is selectively expressed in prostate and ovarian cancers but not in the normal tissues from which they arise. We hypothesized that if exposure to environmental chemicals altered organoid development, the mechanisms might include their effects on the expression of particular protein isoforms (60). To investigate changes in splicing across the proteome, we took advantage of the copious sequence data produced by the MS/MSbased proteomic approach used in this study.…”
Section: Functional Classes Of Proteins and Pathways Changed By Exposmentioning
confidence: 99%